Patents by Inventor Anant Ghongade

Anant Ghongade has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition comprising dapagliflozin
    Patent number: 11660308
    Abstract: The present invention relates to solid oral pharmaceutical compositions comprising amorphous dapagliflozin. The invention further relates to a process for the preparation of the said pharmaceutical compositions. The said compositions are administered orally for the treatment of diabetes mellitus. The said compositions provide the desired immediate release of dapagliflozin and were found to be stable under accelerated conditions.
    Type: Grant
    Filed: May 14, 2021
    Date of Patent: May 30, 2023
    Assignee: INVENTIA HEALTHCARE LIMITED
    Inventors: Vaibhavi Shah, Vijayendrakumar Redasani, Anant Ghongade
  • PHARMACEUTICAL COMPOSITION COMPRISING DAPAGLIFLOZIN
    Publication number: 20210260084
    Abstract: The present invention relates to solid oral pharmaceutical compositions comprising amorphous dapagliflozin. The invention further relates to a process for the preparation of the said pharmaceutical compositions. The said compositions are administered orally for the treatment of diabetes mellitus. The said compositions provide the desired immediate release of dapagliflozin and were found to be stable under accelerated conditions.
    Type: Application
    Filed: May 14, 2021
    Publication date: August 26, 2021
    Inventors: Vaibhavi Shah, Vijayendrakumar Redasani, Anant Ghongade
  • Pharmaceutical composition comprising dapagliflozin
    Patent number: 11020412
    Abstract: The present invention relates to solid oral pharmaceutical compositions comprising amorphous dapagliflozin. The invention further relates to a process for the preparation of the said pharmaceutical compositions. The said compositions are administered orally for the treatment of diabetes mellitus. The said compositions provide the desired immediate release of dapagliflozin and were found to be stable under accelerated conditions.
    Type: Grant
    Filed: February 27, 2018
    Date of Patent: June 1, 2021
    Assignee: INVENTIA HEALTHCARE LIMITED
    Inventors: Vaibhavi Shah, Vijayendrakumar Redasani, Anant Ghongade
  • PHARMACEUTICAL COMPOSITION COMPRISING DAPAGLIFLOZIN
    Publication number: 20200030346
    Abstract: The present invention relates to solid oral pharmaceutical compositions comprising amorphous dapagliflozin. The invention further relates to a process for the preparation of the said pharmaceutical compositions. The said compositions are administered orally for the treatment of diabetes mellitus. The said compositions provide the desired immediate release of dapagliflozin and were found to be stable under accelerated conditions.
    Type: Application
    Filed: February 27, 2018
    Publication date: January 30, 2020
    Inventors: Vaibhavi Shah, Vijayendrakumar Redasani, Anant Ghongade